$2.20 0.02 (+0.92%)
2/13/2012 2:45 PM

Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Featured Broker Partners


Advertisement